Concomitant utilization of oxycodone HCl with CYP3A4 inducers or discontinuation of the CYP3A4 inhibitor could lower oxycodone plasma concentrations, decrease opioid efficacy or, possibly, produce a withdrawal syndrome inside a client who had designed physical dependence to oxycodone.Take into account prescribing naloxone When the affected individu